Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6988 results

Sort By:

MRI-Guided Cryoablation for Focal Native Prostate Cancer

Study ID: NCT04797039
Start Date: 2020-12-01
End Date: 2030-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

MR guided cryoablation

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

Study ID: NCT03521830
Start Date: 2018-11-27
End Date: 2027-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

57

Intervention / Treatment

Nivolumab

Ipilimumab

Relatlimab

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer

Study ID: NCT06548672
Start Date: 2024-06-24
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

148

Intervention / Treatment

With a capacity of 195

Sponsor

Biocity Biopharmaceutics Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

Study ID: NCT06458036
Start Date: 2024-07-29
End Date: 2031-11-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

13

Intervention / Treatment

Selpercatinib Monotherapy

131I Therapy

Sponsor

Children's Hospital of Philadelphia

Source: clinicaltrials.gov

Share:
Add to list

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Study ID: NCT05061550
Start Date: 2022-04-14
End Date: 2030-05-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

630

Intervention / Treatment

Durvalumab

Oleclumab

Monelizumab

Data-DXd

AZD0171

Carboplatin

Cisplatin

Pemetrexed/Cisplatin

Pemetrexed/Carboplatin

Carboplatin/Paclitaxel

Volrustomig

Rilvegostomig

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

Study ID: NCT05143840
Start Date: 2022-04-22
End Date: 2032-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Single Agent Asciminib

Low TKI

Elective Free Treatment

Sponsor

Augusta University

Source: clinicaltrials.gov

Share:
Add to list

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

Study ID: NCT07025512
Start Date: 2025-12-03
End Date: 2029-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

177Lu-PSMA-617

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER

Study ID: NCT07178808
Start Date: 2021-04-16
End Date: 2031-02-22
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Sponsor

Banner Health

Source: clinicaltrials.gov

Share:
Add to list

Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors

Study ID: NCT02146170
Start Date: 2014-05-28
End Date: 2029-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

2000

Intervention / Treatment
Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)

Study ID: NCT05751668
Start Date: 2023-11-02
End Date: 2032-03-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

98

Intervention / Treatment

Paclitaxel

Monosialotetrahexosylganglioside

Administration Questionnaire

Quality-of-life assessment

Placebo Administration

Sponsor

Alliance for Clinical Trials in Oncology

Source: clinicaltrials.gov

Share:
Add to list